Two New Appointees at the NCI

Publication
Article
Oncology NEWS InternationalOncology NEWS International Vol 4 No 9
Volume 4
Issue 9

BETHESDA, Md--Carol Mans-field, MD, professor of radiation oncology, Thomas Jefferson University, Philadelphia, has been appointed chief of NCI's Radiation Research Program. She is former president of the American Radium Society and the American Cancer Society, Philadelphia Division.

BETHESDA, Md--Carol Mans-field, MD, professor of radiation oncology,Thomas Jefferson University, Philadelphia, has been appointedchief of NCI's Radiation Research Program. She is former presidentof the American Radium Society and the American Cancer Society,Philadelphia Division.

Kenneth Cowan, MD, head of the NCI Medicinal Breast Cancer Section,will serve as acting chief of the Medicine Branch, temporarilyreplacing Robert Wittes, MD, acting director of the Division ofCancer Treatment.

Newsletter

Stay up to date on recent advances in the multidisciplinary approach to cancer.

Recent Videos
1 expert is featured in this series.
2 experts are featured in this series.
2 experts are featured in this series.
5 experts are featured in this series
5 experts are featured in this series
2 experts in this video
“If you have a [patient in the] fourth or fifth line, [JNJ-5322] could be a valid drug of choice,” said Rakesh Popat, BSc, MBBS, MRCP, FRCPath, PhD.
2 experts in this video
Earlier treatment with daratumumab may be better tolerated for patients with pretreated MRD-negative multiple myeloma.
The trispecific antibody JNJ-5322 demonstrated superior efficacy vs approved agents in multiple myeloma in results shared at the 2025 EHA Congress.
Related Content